首页 > 最新文献

Bioimpacts最新文献

英文 中文
Interaction of toll-like receptors and ACE-2 with different variants of SARS-CoV-2: A computational analysis. 收费样受体和 ACE-2 与 SARS-CoV-2 不同变种的相互作用:计算分析。
IF 2.2 4区 工程技术 Q3 PHARMACOLOGY & PHARMACY Pub Date : 2024-01-01 Epub Date: 2024-01-06 DOI: 10.34172/bi.2024.30150
Azadeh Zahmatkesh, Elham Salmasi, Reza Gholizadeh

Introduction: Computational studies were performed to investigate the unknown status of endosomal and cell surface receptors in SARS-CoV-2 infection. The interactions between Toll-like receptors (TLRs)- 4/7/8/9 or ACE2 receptor and different SARS-CoV-2 variants were investigated.

Methods: The RNA motifs for TLR7, TLR8 and a CpG motif for TLR9 were analyzed in different variants. Molecular docking and molecular dynamics (MD) simulations were performed to investigate receptor-ligand interactions.

Results: The number of motifs recognized by TLR7/8/9 in the Alpha, Delta and Iranian variants was lower than in the wild type (WT). Docking analysis revealed that the Alpha, Delta and some Iranian spike variants had a higher affinity for ACE2 and TLR4 than the WT, which may account for their higher transmission rate. The MD simulation also showed differences in stability and structure size between the variants and the WT, indicating potential variations in viral load.

Conclusion: It appears that Alpha and some Iranian isolates are the variants of concern due to their higher transmissibility and rapid spread. The Delta mutant is also a variant of concern, not only because of its closer interaction with ACE2, but also with TLR4. Our results emphasize the importance of ACE2 and TLR4, rather than endosomal TLRs, in mediating the effects of different viral mutations and suggest their potential therapeutic applications.

简介为了研究SARS-CoV-2感染中内体和细胞表面受体的未知状态,我们进行了计算研究。研究了Toll样受体(TLRs)- 4/7/8/9或ACE2受体与不同SARS-CoV-2变体之间的相互作用:方法:分析了不同变体中TLR7、TLR8的RNA基团和TLR9的CpG基团。进行了分子对接和分子动力学(MD)模拟,以研究受体与配体之间的相互作用:结果:在 Alpha、Delta 和 Iranian 变体中,TLR7/8/9 识别的基团数量低于野生型(WT)。对接分析表明,与 WT 相比,Alpha、Delta 和一些伊朗尖峰变体与 ACE2 和 TLR4 的亲和力更高,这可能是它们传播率更高的原因。MD 模拟还显示了变体与 WT 在稳定性和结构大小上的差异,这表明病毒载量可能存在变化:结论:Alpha 和一些伊朗分离株似乎是值得关注的变异株,因为它们的传播性更高,传播速度更快。Delta 突变体也是一个值得关注的变体,这不仅是因为它与 ACE2 的相互作用更密切,还因为它与 TLR4 的相互作用更密切。我们的研究结果强调了 ACE2 和 TLR4(而非内体 TLR)在介导不同病毒突变效应方面的重要性,并提出了它们的潜在治疗应用。
{"title":"Interaction of toll-like receptors and ACE-2 with different variants of SARS-CoV-2: A computational analysis.","authors":"Azadeh Zahmatkesh, Elham Salmasi, Reza Gholizadeh","doi":"10.34172/bi.2024.30150","DOIUrl":"10.34172/bi.2024.30150","url":null,"abstract":"<p><p></p><p><strong>Introduction: </strong>Computational studies were performed to investigate the unknown status of endosomal and cell surface receptors in SARS-CoV-2 infection. The interactions between Toll-like receptors (TLRs)- 4/7/8/9 or ACE2 receptor and different SARS-CoV-2 variants were investigated.</p><p><strong>Methods: </strong>The RNA motifs for TLR7, TLR8 and a CpG motif for TLR9 were analyzed in different variants. Molecular docking and molecular dynamics (MD) simulations were performed to investigate receptor-ligand interactions.</p><p><strong>Results: </strong>The number of motifs recognized by TLR7/8/9 in the Alpha, Delta and Iranian variants was lower than in the wild type (WT). Docking analysis revealed that the Alpha, Delta and some Iranian spike variants had a higher affinity for ACE2 and TLR4 than the WT, which may account for their higher transmission rate. The MD simulation also showed differences in stability and structure size between the variants and the WT, indicating potential variations in viral load.</p><p><strong>Conclusion: </strong>It appears that Alpha and some Iranian isolates are the variants of concern due to their higher transmissibility and rapid spread. The Delta mutant is also a variant of concern, not only because of its closer interaction with ACE2, but also with TLR4. Our results emphasize the importance of ACE2 and TLR4, rather than endosomal TLRs, in mediating the effects of different viral mutations and suggest their potential therapeutic applications.</p>","PeriodicalId":48614,"journal":{"name":"Bioimpacts","volume":"14 4","pages":"30150"},"PeriodicalIF":2.2,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11298020/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141894628","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"工程技术","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Integrating rapamycin with novel PI3K/Akt/mTOR inhibitor microRNAs on NOTCH1-driven T-cell acute lymphoblastic leukemia (T-ALL). 将雷帕霉素与新型 PI3K/Akt/mTOR 抑制剂 microRNAs 结合应用于 NOTCH1 驱动的 T 细胞急性淋巴细胞白血病(T-ALL)。
IF 2.2 4区 工程技术 Q3 PHARMACOLOGY & PHARMACY Pub Date : 2024-01-01 Epub Date: 2023-11-28 DOI: 10.34172/bi.2023.28870
Fateme Arjmand, Samaneh Shojaei, Mitra Khalili, Hossein Dinmohammadi, Behzad Poopak, Samira Mohammadi-Yeganeh, Yousef Mortazavi

Introduction: The PI3K/AKT/mTOR signaling pathway plays a significant role in the development of T-cell acute lymphoblastic leukemia (T-ALL). Rapamycin is a potential therapeutic strategy for hematological malignancies due to its ability to suppress mTOR activity. Additionally, microRNAs (miRNAs) have emerged as key regulators in T-ALL pathophysiology and treatment. This study aimed to investigate the combined effects of rapamycin and miRNAs in inhibiting the PI3K/AKT/mTOR pathway in T-ALL cells.

Methods: Bioinformatic algorithms were used to find miRNAs that inhibit the PI3K/AKT/mTOR pathway. Twenty-five bone marrow samples were collected from T-ALL patients, alongside five control bone marrow samples from non-leukemia patients. The Jurkat cell line was chosen as a representative model for T-ALL. Gene and miRNA expression levels were assessed using quantitative real-time PCR (qRT-PCR). Two miRNAs exhibiting down-regulation in both clinical samples and Jurkat cells were transfected to the Jurkat cell line to investigate their impact on target gene expression. Furthermore, in order to evaluate the potential of combination therapy involving miRNAs and rapamycin, apoptosis and cell cycle assays were carried out.

Results: Six miRNAs (miR-3143, miR-3182, miR-99a/100, miR-155, miR-576-5p, and miR-501- 3p) were predicted as inhibitors of PI3K/AKT/mTOR pathway. The expression analysis of both clinical samples and the Jurkat cell line revealed a simultaneous downregulation of miR-3143 and miR-3182. Transfection investigation demonstrated that the exogenous overexpression of miR-3143 and miR-3182 can effectively inhibit PI3K/AKT/mTOR signaling in the Jurkat cell line. Moreover, when used as a dual inhibitor along with rapamycin, miR-3143 and miR-3182 significantly increased apoptosis and caused cell cycle arrest in the Jurkat cell line.

Conclusion: These preliminary results highlight the potential for improving T-ALL treatment through multi-targeted therapeutic strategies involving rapamycin and miR-3143/miR-3182.

导言PI3K/AKT/mTOR信号通路在T细胞急性淋巴细胞白血病(T-ALL)的发病过程中起着重要作用。雷帕霉素能抑制 mTOR 的活性,因此是血液恶性肿瘤的潜在治疗策略。此外,微RNA(miRNA)已成为T-ALL病理生理学和治疗中的关键调控因子。本研究旨在探讨雷帕霉素和miRNAs在T-ALL细胞中抑制PI3K/AKT/mTOR通路的联合作用:方法:利用生物信息学算法寻找抑制PI3K/AKT/mTOR通路的miRNA。研究人员收集了 25 份 T-ALL 患者的骨髓样本和 5 份非白血病患者的对照骨髓样本。选择 Jurkat 细胞系作为 T-ALL 的代表模型。采用定量实时 PCR(qRT-PCR)技术评估基因和 miRNA 的表达水平。将两种在临床样本和 Jurkat 细胞中均表现出下调的 miRNA 转染到 Jurkat 细胞系中,以研究它们对靶基因表达的影响。此外,为了评估 miRNA 与雷帕霉素联合疗法的潜力,还进行了细胞凋亡和细胞周期测定:结果:六个 miRNA(miR-3143、miR-3182、miR-99a/100、miR-155、miR-576-5p 和 miR-501-3p)被预测为 PI3K/AKT/mTOR 通路的抑制剂。对临床样本和 Jurkat 细胞系的表达分析表明,miR-3143 和 miR-3182 同时下调。转染研究表明,外源过表达 miR-3143 和 miR-3182 能有效抑制 Jurkat 细胞系中的 PI3K/AKT/mTOR 信号传导。此外,当 miR-3143 和 miR-3182 与雷帕霉素一起作为双重抑制剂使用时,可显著增加 Jurkat 细胞系的细胞凋亡并导致细胞周期停滞:这些初步结果凸显了通过雷帕霉素和 miR-3143/miR-3182 的多靶点治疗策略改善 T-ALL 治疗的潜力。
{"title":"Integrating rapamycin with novel PI3K/Akt/mTOR inhibitor microRNAs on NOTCH1-driven T-cell acute lymphoblastic leukemia (T-ALL).","authors":"Fateme Arjmand, Samaneh Shojaei, Mitra Khalili, Hossein Dinmohammadi, Behzad Poopak, Samira Mohammadi-Yeganeh, Yousef Mortazavi","doi":"10.34172/bi.2023.28870","DOIUrl":"10.34172/bi.2023.28870","url":null,"abstract":"<p><p></p><p><strong>Introduction: </strong>The PI3K/AKT/mTOR signaling pathway plays a significant role in the development of T-cell acute lymphoblastic leukemia (T-ALL). Rapamycin is a potential therapeutic strategy for hematological malignancies due to its ability to suppress mTOR activity. Additionally, microRNAs (miRNAs) have emerged as key regulators in T-ALL pathophysiology and treatment. This study aimed to investigate the combined effects of rapamycin and miRNAs in inhibiting the PI3K/AKT/mTOR pathway in T-ALL cells.</p><p><strong>Methods: </strong>Bioinformatic algorithms were used to find miRNAs that inhibit the PI3K/AKT/mTOR pathway. Twenty-five bone marrow samples were collected from T-ALL patients, alongside five control bone marrow samples from non-leukemia patients. The Jurkat cell line was chosen as a representative model for T-ALL. Gene and miRNA expression levels were assessed using quantitative real-time PCR (qRT-PCR). Two miRNAs exhibiting down-regulation in both clinical samples and Jurkat cells were transfected to the Jurkat cell line to investigate their impact on target gene expression. Furthermore, in order to evaluate the potential of combination therapy involving miRNAs and rapamycin, apoptosis and cell cycle assays were carried out.</p><p><strong>Results: </strong>Six miRNAs (miR-3143, miR-3182, miR-99a/100, miR-155, miR-576-5p, and miR-501- 3p) were predicted as inhibitors of PI3K/AKT/mTOR pathway. The expression analysis of both clinical samples and the Jurkat cell line revealed a simultaneous downregulation of miR-3143 and miR-3182. Transfection investigation demonstrated that the exogenous overexpression of miR-3143 and miR-3182 can effectively inhibit PI3K/AKT/mTOR signaling in the Jurkat cell line. Moreover, when used as a dual inhibitor along with rapamycin, miR-3143 and miR-3182 significantly increased apoptosis and caused cell cycle arrest in the Jurkat cell line.</p><p><strong>Conclusion: </strong>These preliminary results highlight the potential for improving T-ALL treatment through multi-targeted therapeutic strategies involving rapamycin and miR-3143/miR-3182.</p>","PeriodicalId":48614,"journal":{"name":"Bioimpacts","volume":"14 4","pages":"28870"},"PeriodicalIF":2.2,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11298021/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141894627","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"工程技术","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Synergism of d-limonene and temozolomide on migratory and apoptotic behaviors of human glioblastoma cell lines. d-柠檬烯和替莫唑胺对人类胶质母细胞瘤细胞株迁移和凋亡行为的协同作用。
IF 2.2 4区 工程技术 Q3 PHARMACOLOGY & PHARMACY Pub Date : 2024-01-01 Epub Date: 2023-10-24 DOI: 10.34172/bi.2023.27681
Megha Gautam, Reema Gabrani

Introduction: Glioblastoma (GBM), which is a heterogeneous and aggressive type of brain tumor, is known for its poor survival outcomes. The treatment of GBM remains challenging primarily due to the drug resistance to the current standard therapeutic option, temozolomide (TMZ). Researchers are currently focusing on developing an appropriate alternative combinatorial therapeutic to enhance treatment outcomes. D-limonene (DL) is a monoterpene derived from citrus fruit. This study aims to assess the impact of combining DL with TMZ and explore its potential mechanism of action in U87MG and LN229 GBM cells.

Methods: The effects of the combined treatment of DL and TMZ were assessed on various cellular aspects, including cell viability, anchorage-independent cell growth, and DNA damage. Furthermore, the influence of this combination on cell cycle progression, cell migration, and cell death was also investigated.

Results: The combination of DL+TMZ demonstrated a synergistic effect, resulting in reduced cell proliferation and suppressing the colony formation ability of a single cell. Treatment with DL and TMZ arrested the cells in G0/G1 phase. Furthermore, the DL+TMZ combination induced apoptosis by upregulating the expression of Bax, and Caspase (CASP)-3, while reducing the expression of the Bcl-2 gene in GBM cells. In addition, the combined treatment of DL+TMZ significantly decreased the expression of matrix metalloproteinase (MMP)-2 and MMP-9, expression, indicating inhibition of cell migration in GBM cells.

Conclusion: In conclusion, the combination of DL and TMZ demonstrated a synergistic effect in reducing cell proliferation, suppressing colony formation, inducing apoptosis, and inhibiting cell migration in GBM cells. These findings suggest the potential of DL+TMZ combination therapy as an effective treatment for GBM.

简介胶质母细胞瘤(GBM)是一种异质性侵袭性脑肿瘤,以生存率低而闻名。由于目前的标准疗法替莫唑胺(TMZ)存在耐药性,GBM 的治疗仍面临挑战。研究人员目前正致力于开发一种合适的替代组合疗法,以提高治疗效果。D-柠檬烯(DL)是从柑橘类水果中提取的单萜。本研究旨在评估 DL 与 TMZ 联用的影响,并探索其在 U87MG 和 LN229 GBM 细胞中的潜在作用机制:方法:评估了 DL 和 TMZ 联合治疗对细胞各方面的影响,包括细胞活力、锚碇依赖性细胞生长和 DNA 损伤。此外,还研究了这一组合对细胞周期进展、细胞迁移和细胞死亡的影响:结果:DL+TMZ 的组合具有协同作用,可减少细胞增殖并抑制单个细胞的集落形成能力。DL和TMZ处理后,细胞停滞在G0/G1期。此外,DL+TMZ 组合通过上调 Bax 和 Caspase(CASP)-3 的表达诱导细胞凋亡,同时降低 GBM 细胞中 Bcl-2 基因的表达。此外,DL+TMZ联合治疗可明显降低基质金属蛋白酶(MMP)-2和MMP-9的表达,从而抑制GBM细胞的迁移:总之,DL和TMZ联合用药在减少GBM细胞增殖、抑制集落形成、诱导细胞凋亡和抑制细胞迁移方面具有协同作用。这些研究结果表明,DL+TMZ联合疗法有望成为治疗GBM的有效方法。
{"title":"Synergism of d-limonene and temozolomide on migratory and apoptotic behaviors of human glioblastoma cell lines.","authors":"Megha Gautam, Reema Gabrani","doi":"10.34172/bi.2023.27681","DOIUrl":"https://doi.org/10.34172/bi.2023.27681","url":null,"abstract":"<p><p></p><p><strong>Introduction: </strong>Glioblastoma (GBM), which is a heterogeneous and aggressive type of brain tumor, is known for its poor survival outcomes. The treatment of GBM remains challenging primarily due to the drug resistance to the current standard therapeutic option, temozolomide (TMZ). Researchers are currently focusing on developing an appropriate alternative combinatorial therapeutic to enhance treatment outcomes. D-limonene (DL) is a monoterpene derived from citrus fruit. This study aims to assess the impact of combining DL with TMZ and explore its potential mechanism of action in U87MG and LN229 GBM cells.</p><p><strong>Methods: </strong>The effects of the combined treatment of DL and TMZ were assessed on various cellular aspects, including cell viability, anchorage-independent cell growth, and DNA damage. Furthermore, the influence of this combination on cell cycle progression, cell migration, and cell death was also investigated.</p><p><strong>Results: </strong>The combination of DL+TMZ demonstrated a synergistic effect, resulting in reduced cell proliferation and suppressing the colony formation ability of a single cell. Treatment with DL and TMZ arrested the cells in G0/G1 phase. Furthermore, the DL+TMZ combination induced apoptosis by upregulating the expression of Bax, and Caspase (CASP)-3, while reducing the expression of the Bcl-2 gene in GBM cells. In addition, the combined treatment of DL+TMZ significantly decreased the expression of matrix metalloproteinase (MMP)-2 and MMP-9, expression, indicating inhibition of cell migration in GBM cells.</p><p><strong>Conclusion: </strong>In conclusion, the combination of DL and TMZ demonstrated a synergistic effect in reducing cell proliferation, suppressing colony formation, inducing apoptosis, and inhibiting cell migration in GBM cells. These findings suggest the potential of DL+TMZ combination therapy as an effective treatment for GBM.</p>","PeriodicalId":48614,"journal":{"name":"Bioimpacts","volume":"14 5","pages":"27681"},"PeriodicalIF":2.2,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11406426/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142298913","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"工程技术","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Unveiling the biological effects of radio-frequency and extremely-low frequency electromagnetic fields on the central nervous system performance. 揭示射频和极低频电磁场对中枢神经系统性能的生物影响。
IF 2.2 4区 工程技术 Q3 PHARMACOLOGY & PHARMACY Pub Date : 2024-01-01 Epub Date: 2023-12-30 DOI: 10.34172/bi.2023.30064
Ramin Eskandani, Mohammad Ismail Zibaii

Introduction: Radiofrequency electromagnetic radiation (RF-EMR) and extremely low-frequency electromagnetic fields (ELF-EMF) have emerged as noteworthy sources of environmental pollution in the contemporary era. The potential biological impacts of RF-EMR and ELF-EMF exposure on human organs, particularly the central nervous system (CNS), have garnered considerable attention in numerous research studies.

Methods: This article presents a comprehensive yet summarized review of the research on the explicit/implicit effects of RF-EMR and ELF-EMF exposure on CNS performance.

Results: Exposure to RF-EMR can potentially exert adverse effects on the performance of CNS by inducing changes in the permeability of the blood-brain barrier (BBB), neurotransmitter levels, calcium channel regulation, myelin protein structure, the antioxidant defense system, and metabolic processes. However, it is noteworthy that certain reports have suggested that RF-EMR exposure may confer cognitive benefits for various conditions and disorders. ELF-EMF exposure has been associated with the enhancement of CNS performance, marked by improved memory retention, enhanced learning ability, and potential mitigation of neurodegenerative diseases. Nevertheless, it is essential to acknowledge that ELF-EMF exposure has also been linked to the induction of anxiety states, oxidative stress, and alterations in hormonal regulation. Moreover, ELF-EMR exposure alters hippocampal function, notch signaling pathways, the antioxidant defense system, and synaptic activities.

Conclusion: The RF-EMR and ELF-EMF exposures exhibit both beneficial and adverse effects. Nevertheless, the precise conditions and circumstances under which detrimental or beneficial effects manifest (either individually or simultaneously) remain uncertain.

导言:射频电磁辐射(RF-EMR)和极低频电磁场(ELF-EMF)已成为当代值得注意的环境污染源。射频电磁辐射和极低频电磁场暴露对人体器官,尤其是中枢神经系统(CNS)的潜在生物影响,在众多研究中引起了广泛关注:本文对射频-电磁辐射和电致发光-电磁场暴露对中枢神经系统表现的显性/隐性影响的研究进行了全面而简要的综述:结果:暴露于射频-电磁场可能会引起血脑屏障(BBB)通透性、神经递质水平、钙通道调节、髓鞘蛋白结构、抗氧化防御系统和新陈代谢过程的变化,从而对中枢神经系统的性能产生不利影响。不过,值得注意的是,某些报告指出,暴露于射频-电磁场可能会对各种状况和疾病的认知能力产生益处。暴露于 ELF-EMF 与提高中枢神经系统的性能有关,其显著特点是改善记忆保持能力、提高学习能力,以及可能缓解神经退行性疾病。然而,必须承认的是,暴露于 ELF-EMF 也与诱发焦虑状态、氧化应激和激素调节的改变有关。此外,暴露于 ELF-EMR 会改变海马功能、notch 信号通路、抗氧化防御系统和突触活动:结论:射频-电磁辐射和电场-电磁场暴露既有有益的影响,也有不利的影响。结论:暴露于 RF-EMR 和 ELF-EMF 既会产生有益影响,也会产生有害影响。然而,有害或有益影响(单独或同时产生)的确切条件和情况仍不确定。
{"title":"Unveiling the biological effects of radio-frequency and extremely-low frequency electromagnetic fields on the central nervous system performance.","authors":"Ramin Eskandani, Mohammad Ismail Zibaii","doi":"10.34172/bi.2023.30064","DOIUrl":"10.34172/bi.2023.30064","url":null,"abstract":"<p><p></p><p><strong>Introduction: </strong>Radiofrequency electromagnetic radiation (RF-EMR) and extremely low-frequency electromagnetic fields (ELF-EMF) have emerged as noteworthy sources of environmental pollution in the contemporary era. The potential biological impacts of RF-EMR and ELF-EMF exposure on human organs, particularly the central nervous system (CNS), have garnered considerable attention in numerous research studies.</p><p><strong>Methods: </strong>This article presents a comprehensive yet summarized review of the research on the explicit/implicit effects of RF-EMR and ELF-EMF exposure on CNS performance.</p><p><strong>Results: </strong>Exposure to RF-EMR can potentially exert adverse effects on the performance of CNS by inducing changes in the permeability of the blood-brain barrier (BBB), neurotransmitter levels, calcium channel regulation, myelin protein structure, the antioxidant defense system, and metabolic processes. However, it is noteworthy that certain reports have suggested that RF-EMR exposure may confer cognitive benefits for various conditions and disorders. ELF-EMF exposure has been associated with the enhancement of CNS performance, marked by improved memory retention, enhanced learning ability, and potential mitigation of neurodegenerative diseases. Nevertheless, it is essential to acknowledge that ELF-EMF exposure has also been linked to the induction of anxiety states, oxidative stress, and alterations in hormonal regulation. Moreover, ELF-EMR exposure alters hippocampal function, notch signaling pathways, the antioxidant defense system, and synaptic activities.</p><p><strong>Conclusion: </strong>The RF-EMR and ELF-EMF exposures exhibit both beneficial and adverse effects. Nevertheless, the precise conditions and circumstances under which detrimental or beneficial effects manifest (either individually or simultaneously) remain uncertain.</p>","PeriodicalId":48614,"journal":{"name":"Bioimpacts","volume":"14 4","pages":"30064"},"PeriodicalIF":2.2,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11298025/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141894663","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"工程技术","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Design and implementation of a lab-on-a-chip for assisted reproductive technologies. 辅助生殖技术芯片实验室的设计与实施。
IF 2.2 4区 工程技术 Q3 PHARMACOLOGY & PHARMACY Pub Date : 2024-01-01 Epub Date: 2023-12-10 DOI: 10.34172/bi.2023.28902
Firooz Safaefar, Javad Karamdel, Hadi Veladi, Masoud Maleki

Introduction: The microfluidic device is highly optimized to remove oocytes from the cumulus-corona cell mass surrounding them. Additionally, it effectively captures and immobilizes the oocytes, aiding in assessing their quality and facilitating the injection of sperm into the oocyte. In this study, a novel microfluidic chip was designed and manufactured using conventional soft lithography methods.

Methods: This research proposes the utilization of a microfluidic chip as a substitute for the conventional manual procedures involved in oocyte denudation, trapping, and immobilization. The microfluidic chip was modeled and simulated using COMSOL Multiphysics® 5.2 software to optimize and enhance its design and performance. The microfluidic chip was fabricated using conventional injection molding techniques on a polydimethylsiloxane substrate by employing soft lithography methods.

Results: A hydrostatic force was applied to guide the oocyte through predetermined pathways to eliminate the cumulus cells surrounding the oocyte. The oocyte was subsequently confined within the designated trap region by utilizing hydraulic resistance along the paths and immobilized by applying vacuum force.

Conclusion: The application of this chip necessitates a lower level of operator expertise compared to enzymatic and mechanical techniques. Moreover, it is feasible to continuously monitor the oocyte's state throughout the procedure. There is a reduced need for cultural media compared to more standard approaches.

简介微流体设备经过高度优化,可将卵母细胞从其周围的积液-副细胞团中取出。此外,它还能有效捕获并固定卵母细胞,有助于评估卵母细胞的质量,并方便将精子注入卵母细胞。本研究采用传统的软光刻方法设计并制造了一种新型微流控芯片:本研究提出利用微流体芯片替代传统的人工去核、捕获和固定卵母细胞的方法。使用 COMSOL Multiphysics® 5.2 软件对微流体芯片进行建模和模拟,以优化和提高其设计和性能。采用软光刻方法,在聚二甲基硅氧烷基底上使用传统注塑技术制作了微流控芯片:应用静水压力引导卵母细胞通过预定路径,消除卵母细胞周围的积层细胞。随后,利用路径上的液压阻力将卵母细胞限制在指定的捕获区域内,并通过施加真空力将其固定:结论:与酶解技术和机械技术相比,这种芯片的应用对操作人员的专业技能要求较低。此外,在整个过程中持续监测卵母细胞的状态也是可行的。与标准方法相比,对培养基的需求也有所减少。
{"title":"Design and implementation of a lab-on-a-chip for assisted reproductive technologies.","authors":"Firooz Safaefar, Javad Karamdel, Hadi Veladi, Masoud Maleki","doi":"10.34172/bi.2023.28902","DOIUrl":"10.34172/bi.2023.28902","url":null,"abstract":"<p><p></p><p><strong>Introduction: </strong>The microfluidic device is highly optimized to remove oocytes from the cumulus-corona cell mass surrounding them. Additionally, it effectively captures and immobilizes the oocytes, aiding in assessing their quality and facilitating the injection of sperm into the oocyte. In this study, a novel microfluidic chip was designed and manufactured using conventional soft lithography methods.</p><p><strong>Methods: </strong>This research proposes the utilization of a microfluidic chip as a substitute for the conventional manual procedures involved in oocyte denudation, trapping, and immobilization. The microfluidic chip was modeled and simulated using COMSOL Multiphysics® 5.2 software to optimize and enhance its design and performance. The microfluidic chip was fabricated using conventional injection molding techniques on a polydimethylsiloxane substrate by employing soft lithography methods.</p><p><strong>Results: </strong>A hydrostatic force was applied to guide the oocyte through predetermined pathways to eliminate the cumulus cells surrounding the oocyte. The oocyte was subsequently confined within the designated trap region by utilizing hydraulic resistance along the paths and immobilized by applying vacuum force.</p><p><strong>Conclusion: </strong>The application of this chip necessitates a lower level of operator expertise compared to enzymatic and mechanical techniques. Moreover, it is feasible to continuously monitor the oocyte's state throughout the procedure. There is a reduced need for cultural media compared to more standard approaches.</p>","PeriodicalId":48614,"journal":{"name":"Bioimpacts","volume":"14 4","pages":"28902"},"PeriodicalIF":2.2,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11298026/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141894626","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"工程技术","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Telomerase and mitochondria inhibition promote apoptosis and TET2 and ANMT3a expression in triple negative breast cancer cell lines. 抑制端粒酶和线粒体可促进三阴性乳腺癌细胞株的凋亡以及 TET2 和 ANMT3a 的表达。
IF 2.2 4区 工程技术 Q3 PHARMACOLOGY & PHARMACY Pub Date : 2024-01-01 Epub Date: 2023-12-30 DOI: 10.34172/bi.2023.27640
Zeinab Mazloumi, Ali Rafat, Khadijeh Dizaji Asl, Mohammad Karimipour, Dariush Shanehbandi, Mehdi Talebi, Majid Montazer, Ali Akbar Movassaghpour, Alireza Dehnad, Raheleh Farahzadi, Hojjatollah Nozad Charoudeh

Introduction: High metastasis, resistance to common treatments, and high mortality rate, has made triple-negative breast cancer (TNBC) to be the most invasive type of breast cancer. High telomerase activity and mitochondrial biogenesis are involved in breast cancer tumorigenesis. The catalytic subunit of telomerase, telomerase reverse transcriptase (hTERT), plays a role in telomere lengthening and extra-biological functions such as gene expression, mitochondria function, and apoptosis. In this study, it has been aimed to evaluate intrinsic-, extrinsic-apoptosis and DNMT3a and TET2 expression following the inhibition of telomerase and mitochondria respiration in TNBC cell lines.

Methods: TNBC cells were treated with IC50 levels of BIBR1532, tigecycline, and also their combination. Then, telomere length, and DNMT3a, TET2, and hTERT expression were evaluated. Finally, apoptosis rate, apoptosis-related proteins, and genes were analyzed.

Results: The present results showed that IC50 level of telomerase and inhibition of mitochondria respiration induced apoptosis but did not leave any significant effect on telomere length. The results also indicated that telomerase inhibition induced extrinsic-apoptosis in MDA-MB-231 and caused intrinsic- apoptosis in MDA-MB-468 cells. Furthermore, it was found that the expression of p53 decreased and was ineffective in cell apoptosis. The expressions of DNMT3a and TET2 increased in cells. In addition, combination treatment was better than BIBR1532 and tigecycline alone.

Conclusion: The inhibition of telomerase and mitochondria respiration caused intrinsic- and extrinsic- apoptosis and increased DNMT3a and TET2 expression and it could be utilized in breast cancer treatment.

简介三阴性乳腺癌(TNBC)具有高转移性、对普通治疗方法的耐药性和高死亡率,是侵袭性最强的乳腺癌类型。高端粒酶活性和线粒体生物生成参与了乳腺癌的肿瘤发生。端粒酶的催化亚基--端粒酶逆转录酶(hTERT)在端粒延长以及基因表达、线粒体功能和细胞凋亡等生物外功能中发挥作用。本研究旨在评估 TNBC 细胞株在端粒酶和线粒体呼吸受到抑制后的内在凋亡、外在凋亡以及 DNMT3a 和 TET2 的表达情况:用IC50水平的BIBR1532、替加环素以及它们的组合处理TNBC细胞。然后,评估端粒长度、DNMT3a、TET2 和 hTERT 的表达。最后,分析了细胞凋亡率、凋亡相关蛋白和基因:结果表明,端粒酶的IC50水平和线粒体呼吸抑制可诱导细胞凋亡,但对端粒长度无明显影响。结果还表明,端粒酶抑制在MDA-MB-231细胞中诱导外源性凋亡,在MDA-MB-468细胞中诱导内源性凋亡。此外,研究还发现 p53 的表达减少,对细胞凋亡无效。细胞中 DNMT3a 和 TET2 的表达增加。此外,联合治疗的效果优于单独使用 BIBR1532 和替加环素:结论:抑制端粒酶和线粒体呼吸可导致细胞内在和外在凋亡,增加 DNMT3a 和 TET2 的表达,可用于乳腺癌的治疗。
{"title":"Telomerase and mitochondria inhibition promote apoptosis and TET2 and ANMT3a expression in triple negative breast cancer cell lines.","authors":"Zeinab Mazloumi, Ali Rafat, Khadijeh Dizaji Asl, Mohammad Karimipour, Dariush Shanehbandi, Mehdi Talebi, Majid Montazer, Ali Akbar Movassaghpour, Alireza Dehnad, Raheleh Farahzadi, Hojjatollah Nozad Charoudeh","doi":"10.34172/bi.2023.27640","DOIUrl":"10.34172/bi.2023.27640","url":null,"abstract":"<p><p></p><p><strong>Introduction: </strong>High metastasis, resistance to common treatments, and high mortality rate, has made triple-negative breast cancer (TNBC) to be the most invasive type of breast cancer. High telomerase activity and mitochondrial biogenesis are involved in breast cancer tumorigenesis. The catalytic subunit of telomerase, telomerase reverse transcriptase (hTERT), plays a role in telomere lengthening and extra-biological functions such as gene expression, mitochondria function, and apoptosis. In this study, it has been aimed to evaluate intrinsic-, extrinsic-apoptosis and DNMT3a and TET2 expression following the inhibition of telomerase and mitochondria respiration in TNBC cell lines.</p><p><strong>Methods: </strong>TNBC cells were treated with IC<sub>50</sub> levels of BIBR1532, tigecycline, and also their combination. Then, telomere length, and DNMT3a, TET2, and hTERT expression were evaluated. Finally, apoptosis rate, apoptosis-related proteins, and genes were analyzed.</p><p><strong>Results: </strong>The present results showed that IC<sub>50</sub> level of telomerase and inhibition of mitochondria respiration induced apoptosis but did not leave any significant effect on telomere length. The results also indicated that telomerase inhibition induced extrinsic-apoptosis in MDA-MB-231 and caused intrinsic- apoptosis in MDA-MB-468 cells. Furthermore, it was found that the expression of p53 decreased and was ineffective in cell apoptosis. The expressions of DNMT3a and TET2 increased in cells. In addition, combination treatment was better than BIBR1532 and tigecycline alone.</p><p><strong>Conclusion: </strong>The inhibition of telomerase and mitochondria respiration caused intrinsic- and extrinsic- apoptosis and increased DNMT3a and TET2 expression and it could be utilized in breast cancer treatment.</p>","PeriodicalId":48614,"journal":{"name":"Bioimpacts","volume":"14 4","pages":"27640"},"PeriodicalIF":2.2,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11298022/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141894630","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"工程技术","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cooperatively inhibition effect of miR-143-5p and miR-145-5p in tumorigenesis of glioblastoma cells through modulating AKT signaling pathway miR-143-5p和miR-145-5p通过调节AKT信号通路在胶质母细胞瘤细胞发生中的协同抑制作用
4区 工程技术 Q3 PHARMACOLOGY & PHARMACY Pub Date : 2023-11-05 DOI: 10.34172/bi.2023.29913
Sheyda Jodeiry Zaer, Mahmoudreza Aghamaali, Mohammad Amini, Mohammad Amin Doustvandi, Seyed Samad Hosseini, Behzad Baradaran, Souzan Najafi, Yalda Baghay Esfandyari, Ahad Mokhtarzadeh
Introduction: As the most common aggressive primary brain tumor, glioblastoma is inevitably a recurrent malignancy whose patients’ prognosis is poor. miR-143 and miR-145, as tumor suppressor miRNAs, are downregulated through tumorigenesis of multiple human cancers, including glioblastoma. These two miRNAs regulate numerous cellular processes, such as proliferation and migration. This research was intended to explore the simultaneous replacement effect of miR-143, and miR-145 on in vitro tumorgenicity of U87 glioblastoma cells. Methods: U87 cells were cultured, and transfected with miR-143-5p and miR-145-5p. Afterward, the changes in cell viability, and apoptosis induction were determined by MTT assay and Annexin V/PI staining. The accumulation of cells at the cell cycle phases was assessed using the flow cytometry. Wound healing and colony formation assays were performed to study cell migration. qRT-PCR and western blot techniques were utilized to quantify gene expression levels. Results: Our results showed that miR-143-5p and 145-5p exogenous upregulation cooperatively diminished cell viability, and enhanced U-87 cell apoptosis by modulating Caspase-3/8/9, Bax, and Bcl-2 protein expression. The combination therapy increased accumulation of cells at the sub-G1 phase by modulating CDK1, Cyclin D1, and P53 protein expression. miR-143/145-5p significantly decreased cell migration, and reduced colony formation ability by the downregulation of c-Myc and CD44 gene expression. Furthermore, the results showed the combination therapy of these miRNAs could remarkably downregulate phosphorylated-AKT expression levels. Conclusion: In conclusion, miR-143 and miR-145 were indicated to show cooperative anti- cancer effects on glioblastoma cells via modulating AKT signaling as a new therapeutic approach.
胶质母细胞瘤是脑肿瘤中最常见的侵袭性原发肿瘤,是复发性恶性肿瘤,患者预后较差。miR-143和miR-145作为肿瘤抑制mirna,在包括胶质母细胞瘤在内的多种人类癌症的肿瘤发生过程中下调。这两种mirna调节许多细胞过程,如增殖和迁移。本研究旨在探讨miR-143和miR-145对U87胶质母细胞瘤细胞体外致瘤性的同时替代作用。方法:培养U87细胞,转染miR-143-5p和miR-145-5p。MTT法、Annexin V/PI染色检测细胞活力变化及诱导凋亡情况。利用流式细胞术评估细胞周期阶段细胞的积累情况。进行伤口愈合和菌落形成试验以研究细胞迁移。采用qRT-PCR和western blot技术定量基因表达水平。结果:我们的研究结果显示,miR-143-5p和145-5p外源性上调通过调节Caspase-3/8/9、Bax和Bcl-2蛋白的表达,共同降低细胞活力,促进U-87细胞凋亡。联合治疗通过调节CDK1、Cyclin D1和P53蛋白表达增加了亚g1期细胞的积累。miR-143/145-5p通过下调c-Myc和CD44基因表达,显著降低细胞迁移,降低集落形成能力。此外,结果表明,这些miRNAs联合治疗可显著下调磷酸化akt的表达水平。结论:miR-143和miR-145通过调控AKT信号通路对胶质母细胞瘤细胞发挥协同抗癌作用,是一种新的治疗途径。
{"title":"Cooperatively inhibition effect of miR-143-5p and miR-145-5p in tumorigenesis of glioblastoma cells through modulating AKT signaling pathway","authors":"Sheyda Jodeiry Zaer, Mahmoudreza Aghamaali, Mohammad Amini, Mohammad Amin Doustvandi, Seyed Samad Hosseini, Behzad Baradaran, Souzan Najafi, Yalda Baghay Esfandyari, Ahad Mokhtarzadeh","doi":"10.34172/bi.2023.29913","DOIUrl":"https://doi.org/10.34172/bi.2023.29913","url":null,"abstract":"Introduction: As the most common aggressive primary brain tumor, glioblastoma is inevitably a recurrent malignancy whose patients’ prognosis is poor. miR-143 and miR-145, as tumor suppressor miRNAs, are downregulated through tumorigenesis of multiple human cancers, including glioblastoma. These two miRNAs regulate numerous cellular processes, such as proliferation and migration. This research was intended to explore the simultaneous replacement effect of miR-143, and miR-145 on in vitro tumorgenicity of U87 glioblastoma cells. Methods: U87 cells were cultured, and transfected with miR-143-5p and miR-145-5p. Afterward, the changes in cell viability, and apoptosis induction were determined by MTT assay and Annexin V/PI staining. The accumulation of cells at the cell cycle phases was assessed using the flow cytometry. Wound healing and colony formation assays were performed to study cell migration. qRT-PCR and western blot techniques were utilized to quantify gene expression levels. Results: Our results showed that miR-143-5p and 145-5p exogenous upregulation cooperatively diminished cell viability, and enhanced U-87 cell apoptosis by modulating Caspase-3/8/9, Bax, and Bcl-2 protein expression. The combination therapy increased accumulation of cells at the sub-G1 phase by modulating CDK1, Cyclin D1, and P53 protein expression. miR-143/145-5p significantly decreased cell migration, and reduced colony formation ability by the downregulation of c-Myc and CD44 gene expression. Furthermore, the results showed the combination therapy of these miRNAs could remarkably downregulate phosphorylated-AKT expression levels. Conclusion: In conclusion, miR-143 and miR-145 were indicated to show cooperative anti- cancer effects on glioblastoma cells via modulating AKT signaling as a new therapeutic approach.","PeriodicalId":48614,"journal":{"name":"Bioimpacts","volume":"11 2","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-11-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135726732","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"工程技术","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Non-invasive and probeless rapid in-vitro monitoring and quantification of HUVECs counts based on FFT impedimetery 基于FFT阻抗的HUVECs计数无创无探针快速体外监测与定量
4区 工程技术 Q3 PHARMACOLOGY & PHARMACY Pub Date : 2023-10-31 DOI: 10.34172/bi.2023.28854
Jalil Mirzazadeh, Mir Reza Majidi, Parviz Norouzi, Reza Faridi-Majidi, Karim Asadpour-Zeynali
Introduction: The endothelial cells derived from the human vein cord (HUVECs) are used as in-vitro models for studying cellular and molecular pathophysiology, drug and hormones transport mechanisms, or pathways. In these studies, the proliferation and quantity of cells are important features that should be monitored and assessed regularly. So rapid, easy, noninvasive, and inexpensive methods are favorable for this purpose. Methods: In this work, a novel method based on fast Fourier transform square-wave voltammetry (FFTSWV) combined with a 3D printed electrochemical cell including two inserted platinum electrodes was developed for non-invasive and probeless rapid in-vitro monitoring and quantification of human umbilical vein endothelial cells (HUVECs). The electrochemical cell configuration, along with inverted microscope images, provided the capability of easy use, online in-vitro monitoring, and quantification of the cells during proliferation. Results: HUVECs were cultured and proliferated at defined experimental conditions, and standard cell counts in the initial range of 12 500 to 175 000 were prepared and calibrated by using a hemocytometer (Neubauer chamber) counting for electrochemical measurements. The optimum condition, for FFTSWV at a frequency of 100 Hz and 5 mV amplitude, were found to be a safe electrochemical measurement in the cell culture medium. In each run, the impedance or admittance measurement was measured in a 5 seconds time window. The total measurements were fulfilled at 5, 24, and 48 hours after the seeding of the cells, respectively. The recorded microscopic images before every electrochemical assay showed the conformity of morphology and objective counts of cells in every plate well. The proposed electrochemical method showed dynamic linearity in the range of 12 500-265 000 HUVECs 48 hours after the seeding of cells. Conclusion: The proposed electrochemical method can be used as a simple, fast, and noninvasive technique for tracing and monitoring of HUVECs population in in-vitro studies. This method is highly cheap in comparison with other traditional tools. The introduced configuration has the versatility to develop electrodes for the study of various cells and the application of other electrochemical designations.
来源于人静脉索的内皮细胞(HUVECs)被用作体外模型,用于研究细胞和分子病理生理,药物和激素的转运机制或途径。在这些研究中,细胞的增殖和数量是应定期监测和评估的重要特征。因此,快速、简便、无创和廉价的方法是实现这一目的的有利条件。方法:基于快速傅立叶变换方波伏安法(FFTSWV)结合3D打印电化学电池(含两个插入铂电极),开发了一种无创、无探针的体外快速监测和定量人脐静脉内皮细胞(HUVECs)的新方法。电化学电池配置,以及倒置显微镜图像,提供了易于使用的能力,在线体外监测,并在细胞增殖过程中定量。结果:HUVECs在规定的实验条件下进行了培养和增殖,制备了初始范围为12 500 ~ 175 000的标准细胞计数,并使用血细胞计(Neubauer室)计数进行了电化学测量。结果表明,频率为100 Hz,振幅为5 mV的FFTSWV是一种安全的电化学测量方法。在每次运行中,阻抗或导纳测量在5秒的时间窗口内测量。总测量分别在细胞播种后5、24和48小时完成。每次电化学分析前记录的显微镜图像显示每个板孔中细胞的形态和客观计数的一致性。在12 500 ~ 265 000 HUVECs范围内,该电化学方法在细胞播种后48 h呈动态线性关系。结论:该电化学方法可作为一种简便、快速、无创的体外HUVECs种群追踪和监测技术。与其他传统工具相比,这种方法非常便宜。所介绍的结构具有通用性,可用于研究各种电池和其他电化学指定的应用。
{"title":"Non-invasive and probeless rapid in-vitro monitoring and quantification of HUVECs counts based on FFT impedimetery","authors":"Jalil Mirzazadeh, Mir Reza Majidi, Parviz Norouzi, Reza Faridi-Majidi, Karim Asadpour-Zeynali","doi":"10.34172/bi.2023.28854","DOIUrl":"https://doi.org/10.34172/bi.2023.28854","url":null,"abstract":"Introduction: The endothelial cells derived from the human vein cord (HUVECs) are used as in-vitro models for studying cellular and molecular pathophysiology, drug and hormones transport mechanisms, or pathways. In these studies, the proliferation and quantity of cells are important features that should be monitored and assessed regularly. So rapid, easy, noninvasive, and inexpensive methods are favorable for this purpose. Methods: In this work, a novel method based on fast Fourier transform square-wave voltammetry (FFTSWV) combined with a 3D printed electrochemical cell including two inserted platinum electrodes was developed for non-invasive and probeless rapid in-vitro monitoring and quantification of human umbilical vein endothelial cells (HUVECs). The electrochemical cell configuration, along with inverted microscope images, provided the capability of easy use, online in-vitro monitoring, and quantification of the cells during proliferation. Results: HUVECs were cultured and proliferated at defined experimental conditions, and standard cell counts in the initial range of 12 500 to 175 000 were prepared and calibrated by using a hemocytometer (Neubauer chamber) counting for electrochemical measurements. The optimum condition, for FFTSWV at a frequency of 100 Hz and 5 mV amplitude, were found to be a safe electrochemical measurement in the cell culture medium. In each run, the impedance or admittance measurement was measured in a 5 seconds time window. The total measurements were fulfilled at 5, 24, and 48 hours after the seeding of the cells, respectively. The recorded microscopic images before every electrochemical assay showed the conformity of morphology and objective counts of cells in every plate well. The proposed electrochemical method showed dynamic linearity in the range of 12 500-265 000 HUVECs 48 hours after the seeding of cells. Conclusion: The proposed electrochemical method can be used as a simple, fast, and noninvasive technique for tracing and monitoring of HUVECs population in in-vitro studies. This method is highly cheap in comparison with other traditional tools. The introduced configuration has the versatility to develop electrodes for the study of various cells and the application of other electrochemical designations.","PeriodicalId":48614,"journal":{"name":"Bioimpacts","volume":"39 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-10-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135978081","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"工程技术","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Podocyte-specific proteins in urinary extracellular vesicles of patients with IgA nephropathy: Vasorin and ceruloplasmin IgA肾病患者尿细胞外囊泡中足细胞特异性蛋白:血管球蛋白和铜蓝蛋白
4区 工程技术 Q3 PHARMACOLOGY & PHARMACY Pub Date : 2023-10-31 DOI: 10.34172/bi.2023.29981
Negin Farzamikia, Seyyedeh Mina Hejazian, Soroush Mostafavi, Behzad Baradaran, Sepideh Zununi Vahed, Mohammadreza Ardalan
Introduction: Urinary extracellular vesicles (uEVs) can be considered biomarkers of kidney diseases. EVs derived from podocytes may reflect podocyte damage in different glomerular diseases. IgA nephropathy (IgAN) is one of the most common forms of glomerulonephritis (GN) characterized by proteinuria and hematuria. This study aimed to analyze the uEVs of IgAN patients to understand the pathophysiological processes of the disease at the protein level. Methods: Patients with GN [biopsy-proven IgAN (n = 16) and membranous glomerulonephritis (MGN, n = 16)], and healthy controls (n = 16) were included in this study. The uEVs were extracted, characterized, and analyzed to evaluate the protein levels of candidate markers of IgAN, including vasorin precursor, aminopeptidase N, and ceruloplasmin by western-blot analysis. Results: Higher levels of both podocytes and EVs-related proteins were observed in the pooled urine samples of GN patients compared to the healthy controls. In IgAN patients, uEV-protein levels of vasorin were statistically lower while levels of ceruloplasmin were significantly higher compared to MGN (P = 0.002, P = 0.06) and healthy controls, respectively (P = 0.020, P= 0.001). Conclusion: Different levels of the studied proteins in uEVs may indicate podocyte injury and represent a direct association with the pathology of IgAN and MGN.
导读:尿细胞外囊泡(uEVs)可以被认为是肾脏疾病的生物标志物。足细胞衍生的ev可能反映不同肾小球疾病中足细胞的损伤。IgA肾病(IgAN)是肾小球肾炎(GN)最常见的形式之一,以蛋白尿和血尿为特征。本研究旨在分析IgAN患者的uEVs,从蛋白水平了解该病的病理生理过程。方法:选取经活检证实的GN [IgAN, n = 16]和膜性肾小球肾炎(MGN, n = 16)患者及健康对照组(n = 16)。提取、表征和分析uEVs,通过western-blot分析评估IgAN候选标记物的蛋白水平,包括血管球蛋白前体、氨基肽酶N和铜蓝蛋白。结果:与健康对照组相比,在GN患者的尿液样本中观察到更高水平的足细胞和ev相关蛋白。IgAN患者uEV-protein vasorin水平与MGN (P = 0.002, P= 0.06)和健康对照(P = 0.020, P= 0.001)相比,uEV-protein vasorin水平具有统计学意义较低,而铜蓝蛋白水平显著高于MGN (P = 0.002, P= 0.06)。结论:uEVs中不同水平的研究蛋白可能提示足细胞损伤,并与IgAN和MGN的病理直接相关。
{"title":"Podocyte-specific proteins in urinary extracellular vesicles of patients with IgA nephropathy: Vasorin and ceruloplasmin","authors":"Negin Farzamikia, Seyyedeh Mina Hejazian, Soroush Mostafavi, Behzad Baradaran, Sepideh Zununi Vahed, Mohammadreza Ardalan","doi":"10.34172/bi.2023.29981","DOIUrl":"https://doi.org/10.34172/bi.2023.29981","url":null,"abstract":"Introduction: Urinary extracellular vesicles (uEVs) can be considered biomarkers of kidney diseases. EVs derived from podocytes may reflect podocyte damage in different glomerular diseases. IgA nephropathy (IgAN) is one of the most common forms of glomerulonephritis (GN) characterized by proteinuria and hematuria. This study aimed to analyze the uEVs of IgAN patients to understand the pathophysiological processes of the disease at the protein level. Methods: Patients with GN [biopsy-proven IgAN (n = 16) and membranous glomerulonephritis (MGN, n = 16)], and healthy controls (n = 16) were included in this study. The uEVs were extracted, characterized, and analyzed to evaluate the protein levels of candidate markers of IgAN, including vasorin precursor, aminopeptidase N, and ceruloplasmin by western-blot analysis. Results: Higher levels of both podocytes and EVs-related proteins were observed in the pooled urine samples of GN patients compared to the healthy controls. In IgAN patients, uEV-protein levels of vasorin were statistically lower while levels of ceruloplasmin were significantly higher compared to MGN (P = 0.002, P = 0.06) and healthy controls, respectively (P = 0.020, P= 0.001). Conclusion: Different levels of the studied proteins in uEVs may indicate podocyte injury and represent a direct association with the pathology of IgAN and MGN.","PeriodicalId":48614,"journal":{"name":"Bioimpacts","volume":"8 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-10-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135978079","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"工程技术","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Unravelling benzazepines and aminopyrimidine as multi-target therapeutic repurposing drugs for EGFR V774M mutation in neuroglioma patients 苯并氮和氨基嘧啶作为神经胶质瘤患者EGFR V774M突变的多靶点治疗药物的研究
4区 工程技术 Q3 PHARMACOLOGY & PHARMACY Pub Date : 2023-10-24 DOI: 10.34172/bi.2023.28876
Jitender Singh, Krishan L Khanduja, Pramod K Avti
Introduction: Neuroglioma, a classification encompassing tumors arising from glial cells, exhibits variable aggressiveness and depends on tumor grade and stage. Unraveling the EGFR gene alterations, including amplifications (unaltered), deletions, and missense mutations (altered), is emerging in glioma. However, the precise understanding of emerging EGFR mutations and their role in neuroglioma remains limited. This study aims to identify specific EGFR mutations prevalent in neuroglioma patients and investigate their potential as therapeutic targets using FDA- approved drugs for repurposing approach. Methods: Neuroglioma patient’s data were analyzed to identify the various mutations and survival rates. High throughput virtual screening (HTVS) of FDA-approved (1615) drugs using molecular docking and simulation was executed to determine the potential hits. Results: Neuroglioma patient samples (n=4251) analysis reveals 19% EGFR alterations with most missense mutations at V774M in exon 19. The Kaplan-Meier plots show that the overall survival rate was higher in the unaltered group than in the altered group. Docking studies resulted the best hits based on each target's higher docking score, minimum free energy (MMGBSA), minimum kd, ki, and IC50 values. MD simulations and their trajectories show that compounds ZINC000011679756 target unaltered EGFR and ZINC000003978005 targets altered EGFR, whereas ZINC000012503187 (Conivaptan, Benzazepine) and ZINC000068153186 (Dabrafenib, aminopyrimidine) target both the EGFRs. The shortlisted compounds demonstrate favorable residual interactions with their respective targets, forming highly stable complexes. Moreover, these shortlisted compounds have drug- like properties as assessed by ADMET profiling. Conclusion: Therefore, compounds (ZINC000012503187 and ZINC000068153186) can effectively target both the unaltered/altered EGFRs as multi-target therapeutic repurposing drugs towards neuroglioma.
神经胶质瘤是一种由神经胶质细胞引起的肿瘤,其侵袭性随肿瘤的分级和分期而变化。揭示EGFR基因的改变,包括扩增(未改变)、缺失和错义突变(改变),正在胶质瘤中出现。然而,对新出现的EGFR突变及其在神经胶质瘤中的作用的精确理解仍然有限。本研究旨在确定神经胶质瘤患者中普遍存在的特异性EGFR突变,并研究它们作为使用FDA批准的药物进行再利用的治疗靶点的潜力。方法:对神经胶质瘤患者的资料进行分析,以确定各种突变和生存率。利用分子对接和模拟技术对fda批准的1615种药物进行高通量虚拟筛选(HTVS),以确定潜在的靶点。结果:神经胶质瘤患者样本(n=4251)分析显示,19%的EGFR改变,大多数错义突变位于第19外显子的V774M。Kaplan-Meier图显示,未改变组的总存活率高于改变组。对接研究根据每个目标较高的对接得分、最小自由能(MMGBSA)、最小kd、ki和IC50值得出最佳命中。MD模拟及其轨迹表明,化合物ZINC000011679756靶向未改变的EGFR, ZINC000003978005靶向改变的EGFR,而ZINC000012503187 (Conivaptan, Benzazepine)和ZINC000068153186 (Dabrafenib, aminopy嘧啶)靶向两种EGFR。候选化合物表现出良好的剩余相互作用与各自的目标,形成高度稳定的配合物。此外,通过ADMET分析,这些候选化合物具有类似药物的性质。结论:因此,化合物(ZINC000012503187和ZINC000068153186)可以有效靶向未改变/改变的egfr作为神经胶质瘤的多靶点治疗药物。
{"title":"Unravelling benzazepines and aminopyrimidine as multi-target therapeutic repurposing drugs for EGFR V774M mutation in neuroglioma patients","authors":"Jitender Singh, Krishan L Khanduja, Pramod K Avti","doi":"10.34172/bi.2023.28876","DOIUrl":"https://doi.org/10.34172/bi.2023.28876","url":null,"abstract":"Introduction: Neuroglioma, a classification encompassing tumors arising from glial cells, exhibits variable aggressiveness and depends on tumor grade and stage. Unraveling the EGFR gene alterations, including amplifications (unaltered), deletions, and missense mutations (altered), is emerging in glioma. However, the precise understanding of emerging EGFR mutations and their role in neuroglioma remains limited. This study aims to identify specific EGFR mutations prevalent in neuroglioma patients and investigate their potential as therapeutic targets using FDA- approved drugs for repurposing approach. Methods: Neuroglioma patient’s data were analyzed to identify the various mutations and survival rates. High throughput virtual screening (HTVS) of FDA-approved (1615) drugs using molecular docking and simulation was executed to determine the potential hits. Results: Neuroglioma patient samples (n=4251) analysis reveals 19% EGFR alterations with most missense mutations at V774M in exon 19. The Kaplan-Meier plots show that the overall survival rate was higher in the unaltered group than in the altered group. Docking studies resulted the best hits based on each target's higher docking score, minimum free energy (MMGBSA), minimum kd, ki, and IC50 values. MD simulations and their trajectories show that compounds ZINC000011679756 target unaltered EGFR and ZINC000003978005 targets altered EGFR, whereas ZINC000012503187 (Conivaptan, Benzazepine) and ZINC000068153186 (Dabrafenib, aminopyrimidine) target both the EGFRs. The shortlisted compounds demonstrate favorable residual interactions with their respective targets, forming highly stable complexes. Moreover, these shortlisted compounds have drug- like properties as assessed by ADMET profiling. Conclusion: Therefore, compounds (ZINC000012503187 and ZINC000068153186) can effectively target both the unaltered/altered EGFRs as multi-target therapeutic repurposing drugs towards neuroglioma.","PeriodicalId":48614,"journal":{"name":"Bioimpacts","volume":"221 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-10-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135322584","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"工程技术","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Bioimpacts
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1